Turkey Sepsis Diagnostic Market Outlook

turkey sepsis diagnostic market outlook (2018 to 2032) in turkey, sepsis is in line with the global burden of healthcare cost. it is estimated that approximately approximately 40-50% of the total mortality is due to sepsis. the cost of sepsis-related diagnosis is estimated to be over $8 billion. furthermore, the increasing number of cases of drug-resistant infections is also increasing the demand for sepsis diagnosis. currently, most sepsis diagnosis in turkey focuses on the identification of potential risk factors for sepsis as well as the recognition and management of sepsis cases. the main diagnostic tool used for sepsis detection is the laboratory tests. to identify organisms responsible for the infection, diagnostic tests such as blood culture, urine culture, and sputum culture are used. additionally, imaging techniques such as chest radiography, ultrasound, computed tomography (ct) scan, and magnetic resonance imaging (mri) can be used to detect any other underlying causes of infection. to further improve the diagnosis capabilities in turkey, laboratory consolidation is one of the major strategies that is being adopted by the government. this consolidation includes the merging of multiple laboratories into a single large laboratory for better services and cost-effectiveness. additionally, this process of laboratory consolidation is being encouraged in private hospitals as well. this will potentially increase the effectiveness of diagnosing sepsis in turkey. in addition, new approaches for diagnosis such as point-of-care testing (poct) is also being encouraged in turkey. the use of poct will help in quick identification of risk factors and the prompt initiation of appropriate therapy. furthermore, the use of artificial intelligence (ai) enabled diagnostic tools is also being explored in turkey. this will provide clinicians with real-time data and accurate results for better decisions in management of sepsis cases. overall, the sepsis diagnostic market in turkey is still in the early stages of development. however, the aforementioned strategies promise to bring more accurate and efficient diagnosis in turkey. going forward, the prevalence of sepsis is likely to remain high, thus fueling the demand for an effective sepsis diagnosis market.